Toronto, Ontario, Canada
Dr. Clokie is an oral and maxillofacial surgeon, scientist and serial entrepreneur. He is the CEO of Red Rock Regeneration, Inc., a regenerative medicine company focused on innovative solutions for musculoskeletal reconstruction. For three decades he was involved in academic dentistry and clinical practice, most recently being named as the Head of Oral and Maxillofacial Surgery in 1998 and then as Professor of Oral and Maxillofacial Surgery at the University of Toronto until his retirement from academics in 2017.
He has also held positions on the boards or scientific advisory boards of several companies. He was a member of the examination committees for the Royal College of Dentist of Canada and the American Board of Oral and Maxillofacial Surgery, where he served as a Section CoChair for two years. At McGill University he served as the Associate Dean of Clinical Affairs until he moved the University of Toronto.
He has published many papers and made numerous presentations, both nationally and internationally on bone reconstruction and regenerative medicine. As a holder of more than 50 US and international existing and/or pending patents, including those related to bone healing, he has been able to successfully develop strategic alliances with businesses and transfer his considerable knowledge and ingenuity into commercially viable enterprises. To date Dr. Clokie’s innovations have led to the commercialization of 5 surgical bioimplants that are currently on the market. The focus of his clinical practice was bone reconstruction in preparation for dental implant placement and he remains committed to the development of innovative technologies designed for dental implant reconstruction and regenerative medicine. As the Chief Executive Officer of Red Rock Regeneration, Inc. Dr. Clokie intends to revolutionize reconstructive musculoskeletal surgery by offering unique regenerative medicine strategies to the marketplace.
GCF2 - Industry Symposium: Induce Biologics: Natural Matrix Proteins: A New Era in Bone Regeneration
Thursday, November 30, 2023
5:00 PM – 6:30 PM CST
Disclosure information not submitted.